MetaCap

CAMP4 Therapeutics (CAMP) News

NASDAQ: CAMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.79-0.21 (-5.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CAMP news summary

We found 4 recent headlines mentioning CAMP4 Therapeutics (CAMP): 1 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. CAMP is making an outsized move today, down 5.25% at $3.79, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)", was published by GlobeNewswire on Nov 17, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest CAMP4 Therapeutics headlines

Compare CAMP